Cited by 225T-cell and B-cell ImmunologyBlood disorders and treatmentsHematopoietic Stem Cell Transplantation

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia

Open access

Solomou, Elena E., Rezvani, Katayoun, Mielke, Stephan, Malide, Daniela, Keyvanfar, Keyvan, Visconte, Valeria, Kajigaya, Sachiko, Barrett, A. John, Young, Neal S.·2007·Blood

DOI 10.1182/blood-2007-01-066258PMC PMC1975843

Open this paper in CoChat — free account

Abstract

Regulatory T cells are believed to control the development and progression of autoimmunity by suppressing autoreactive T cells. Decreased numbers of CD4(+)CD25(+) FOXP3(+) T cells (Tregs) are associated with impaired immune homeostasis and development of autoimmune diseases. The transcription factors FOXP3 and NFAT1 have key roles in regulatory T-cell development and function. We show that Tregs are decreased at presentation in almost all patients with aplastic anemia; FOXP3 protein and mRNA levels also are significantly lower in patients with aplastic anemia and NFAT1 protein levels are decreased or absent. Transfection of FOXP3-deficient CD4(+)CD25(+) T cells from patients with a plasmid encoding wild-type NFAT1 resulted in increased FOXP3 expression in these cells. By NFAT1 knockdown in CD4(+)CD25(+) T cells, FOXP3 expression was decreased when NFAT1 expression was decreased. Our findings indicate that decreased NFAT1 could explain low FOXP3 expression and diminished Treg frequency in aplastic anemia. Treg defects are now implicated in autoimmune marrow failure.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1182/blood-2007-01-066258

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self
Sakaguchi, S. (2005) · Nature Immunology · doi:10.1038/ni1178 · Cited by 2,669
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher‐Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,858
FOXP3 Controls Regulatory T Cell Function through Cooperation with NFAT
Wu, Y., Borde, M., Heissmeyer, V., Feuerer, M., Lapan, A. D., Stroud, J. C., Bates, D. L., Guo, L., Han, A., Ziegler, S. F., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.042 · Cited by 1,229
Current concepts in the pathophysiology and treatment of aplastic anemia
Young, N. S., Calado, R. T., & Scheinberg, P. (2006) · Blood · doi:10.1182/blood-2006-03-010777 · Cited by 888
Self-citation
Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression
Wan, Y. Y., & Flavell, R. A. (2007) · Nature · doi:10.1038/nature05479 · Cited by 876
Toll-like receptor 2 controls expansion and function of regulatory T cells
Sutmuller, R. P. M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25439 · Cited by 750
Regulatory T cells in cancer
Beyer, M., & Schultze, J. L. (2006) · Blood · doi:10.1182/blood-2006-02-002774 · Cited by 741
Multiple immuno-regulatory defects in type-1 diabetes
Kukreja, A., Cost, G., Marker, J., Zhang, C., Sun, Z., Lin‐Su, K., Ten, S., Sanz, M. M., Exley, M. A., Wilson, B., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13605 · Cited by 640
The lifestyle of naturally occurring CD4+CD25+Foxp3+ regulatory T cells
Shevach, E. M., DiPaolo, R. J., Andersson, J., Zhao, D., Stephens, G. L., & Thornton, A. M. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00415.x · Cited by 589
Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis
Gambineri, E., Torgerson, T. R., & Ochs, H. D. (2003) · Current Opinion in Rheumatology · doi:10.1097/00002281-200307000-00010 · Cited by 575

Show all 24 references

Sorted by citations

Aplastic Anemia
Young, N. S. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1413485 · Cited by 762
Self-citation
CAR-HEMATOTOX: a model for CAR T-cell–related hematologic toxicity in relapsed/refractory large B-cell lymphoma
Rejeski, K., Perez, A. P., Sesques, P., Hoster, E., Berger, C., Jentzsch, L., Mougiakakos, D., Frölich, L., Ackermann, J., Bücklein, V., et al. (2021) · Blood · doi:10.1182/blood.2020010543 · Cited by 501
How I treat acquired aplastic anemia
Scheinberg, P., & Young, N. S. (2012) · Blood · doi:10.1182/blood-2011-12-274019 · Cited by 446
Self-citation
Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug
Desmond, R. G., Townsley, D. M., Dumitriu, B., Olnes, M. J., Scheinberg, P., Bevans, M. F., Parikh, A. R., Broder, K., Calvo, K. R., Wu, C. O., et al. (2013) · Blood · doi:10.1182/blood-2013-10-534743 · Cited by 401
Self-citation
Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro
Feng, X., Kajigaya, S., Solomou, E. E., Keyvanfar, K., Xu, X., Raghavachari, N., Munson, P. J., Herndon, T. M., Chen, J., & Young, N. S. (2008) · Blood · doi:10.1182/blood-2008-01-130146 · Cited by 239
Self-citation
Aplastic anemia
Young, N. S., Scheinberg, P., & Calado, R. T. (2008) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3282fa7470 · Cited by 224
Self-citation
Current concepts in the pathophysiology and treatment of aplastic anemia
Young, N. S. (2013) · Hematology · doi:10.1182/asheducation-2013.1.76 · Cited by 199
Self-citation
IL‐17‐producing CD4+T cells, pro‐inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome
Kordasti, S. Y., Afzali, B., Lim, Z., Ingram, W. A., Hayden, J., Barber, L. D., Matthews, K., Chelliah, R., Guinn, B., Lombardi, G., et al. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07593.x · Cited by 198
Th17 immune responses contribute to the pathophysiology of aplastic anemia
de Latour, R. P., Visconte, V., Takaku, T., Wu, C. O., Erie, A. J., Sarcon, A. K., Desierto, M. J., Scheinberg, P., Keyvanfar, K., Núñez, O., et al. (2010) · Blood · doi:10.1182/blood-2010-01-266098 · Cited by 189
Self-citation
Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures
Tran, D. Q., Andersson, J., Hardwick, D., Bebris, L., Illei, G. G., & Shevach, E. M. (2009) · Blood · doi:10.1182/blood-2009-01-199950 · Cited by 187
Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party
Marsh, J. C. W., Bacigalupo, A. P., Schrezenmeier, H., Tichelli, A., Risitano, A. M., Passweg, J. R., Killick, S. B., Warren, A. J., Foukaneli, T., Aljurf, M. D., et al. (2012) · Blood · doi:10.1182/blood-2012-02-407684 · Cited by 181
Functional characterization of CD4+ T cells in aplastic anemia
Kordasti, S. Y., Marsh, J. C. W., Al-Khan, S., Jiang, J., Smith, A., Mohamedali, A. M., Abellan, P. P., Veen, C., Costantini, B., Kulasekararaj, A. G., et al. (2011) · Blood · doi:10.1182/blood-2011-08-368308 · Cited by 176
Kinetics, function and bone marrow trafficking of CD4+CD25+FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS)
Kotsianidis, Ι., Bouchliou, I., Nakou, E., Spanoudakis, E., Margaritis, D., Christophoridou, A. V., Anastasiades, A., Tsigalou, C., Bourikas, G., Karadimitris, A., et al. (2008) · Leukemia · doi:10.1038/leu.2008.333 · Cited by 147
Deep phenotyping of Tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment
Kordasti, S. Y., Costantini, B., Seidl, T., Abellan, P. P., Martínez‐Llordella, M., McLornan, D. P., Diggins, K. E., Kulasekararaj, A. G., Benfatto, C., Feng, X., et al. (2016) · Blood · doi:10.1182/blood-2016-03-703702 · Cited by 145
Self-citation
Intrinsic impairment of CD4+CD25+ regulatory T cells in acquired aplastic anemia
Shi, J., Ge, M., Lu, S., Li, X., Shao, Y., Huang, J., Huang, Z., Zhang, J., Nie, N., & Zheng, Y. (2012) · Blood · doi:10.1182/blood-2011-11-390708 · Cited by 139
Advances in understanding the pathogenesis of acquired aplastic anaemia
Luzzatto, L., & Risitano, A. M. (2018) · British Journal of Haematology · doi:10.1111/bjh.15443 · Cited by 124
Aplastic anemia: Etiology, molecular pathogenesis, and emerging concepts
Shallis, R. M., Ahmad, R., & Zeidan, A. M. (2018) · European Journal Of Haematology · doi:10.1111/ejh.13153 · Cited by 111
Memory Stem T Cells in Autoimmune Disease: High Frequency of Circulating CD8+ Memory Stem Cells in Acquired Aplastic Anemia
Hosokawa, K. T., Muranski, P. J., Feng, X., Townsley, D. M., Liu, B., Knickelbein, J. E., Keyvanfar, K., Dumitriu, B., Ito, S., Kajigaya, S., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501739 · Cited by 102
Self-citation
The Th17/Treg imbalance exists in patients with heart failure with normal ejection fraction and heart failure with reduced ejection fraction
Li, N., Bian, H., Zhang, J., Li, X., Ji, X., & Zhang, Y. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.08.013 · Cited by 101
The Pathophysiology of Acquired Aplastic Anemia
Schoettler, M. L., & Nathan, D. G. (2018) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2018.03.001 · Cited by 101
Regulatory T Cells Are Reduced During Anti-CD25 Antibody Treatment of Multiple Sclerosis
Oh, U., Blevins, G., Griffith, C., Richert, N. D., Maric, D., Lee, C. R., McFarland, H. F., & Jacobson, S. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.16 · Cited by 97
Regulatory T cells for tolerance
Kawai, K., Uchiyama, M., Hester, J., Wood, K. J., & Issa, F. (2017) · Human Immunology · doi:10.1016/j.humimm.2017.12.013 · Cited by 99
Aplastic anemia: Pathophysiology
Giudice, V., & Selleri, C. (2022) · Seminars in Hematology · doi:10.1053/j.seminhematol.2021.12.002 · Cited by 95
Abnormal erythropoiesis and the pathophysiology of chronic anemia
Koury, M. J. (2014) · Blood Reviews · doi:10.1016/j.blre.2014.01.002 · Cited by 98
Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: a single-center retrospective study
Atta, E. H., Dias, D. S. P., Marra, V. N., & de Azevedo, A. M. (2010) · Annals of Hematology · doi:10.1007/s00277-010-0944-y · Cited by 91
Somatic HLA mutations expose the role of class I–mediated autoimmunity in aplastic anemia and its clonal complications
Babushok, D. V., Duke, J. L., Xie, H. M., Stanley, N. L., Atienza, J., Perdigones, N., Nicholas, P., Ferriola, D., Li, Y., Huang, H., et al. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017010918 · Cited by 90
GATA Transcription Factors: Basic Principles and Related Human Disorders
Fujiwara, T. (2017) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.242.83 · Cited by 80
Inflammatory bone marrow microenvironment
Leimkühler, N. B., & Schneider, R. K. (2019) · Hematology · doi:10.1182/hematology.2019000045 · Cited by 82
The incidence, risk factors, and outcomes of primary poor graft function after unmanipulated haploidentical stem cell transplantation
Sun, Y., He, G.-L., Chang, Y., Xu, L., Zhang, X., Han, W., Chen, H., Chen, Y., Wang, Y., Wang, F., et al. (2015) · Annals of Hematology · doi:10.1007/s00277-015-2440-x · Cited by 81
Acquired severe aplastic anaemia: how medical therapy evolved in the 20th and 21st centuries
Scheinberg, P. (2021) · British Journal of Haematology · doi:10.1111/bjh.17403 · Cited by 80
Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children
Jeong, D. C., Chung, N., Cho, B., Zou, Y., Ruan, M., Takahashi, Y., Muramatsu, H., Ohara, A., Kosaka, Y., Yang, W., et al. (2013) · Haematologica · doi:10.3324/haematol.2013.089268 · Cited by 81
Abnormal immunity and stem/progenitor cells in acquired aplastic anemia
Li, J., Zheng, C. L., & Han, Z. (2010) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2009.12.001 · Cited by 68
Activity of eltrombopag in severe aplastic anemia
Scheinberg, P. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018020248 · Cited by 64
Double‐negative regulatory T cells induce allotolerance when expanded after allogeneic haematopoietic stem cell transplantation
McIver, Z. A., Serio, B., Dunbar, A. J., O'Keefe, C., Powers, J., Włodarski, M. W., Jin, T., Sobecks, R. M., Bolwell, B. J., & Maciejewski, J. P. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07021.x · Cited by 60
Isolation strategies of regulatory T cells for clinical trials: Phenotype, function, stability, and expansion capacity
Ukena, S. N., Hoepting, M., Velaga, S., Ivanyi, P., Grosse, J., Baron, U., Ganser, A., & Franzke, A. (2011) · Experimental Hematology · doi:10.1016/j.exphem.2011.08.010 · Cited by 60
Alterations in Hematopoietic Microenvironment in Patients with Aplastic Anemia
Shipounova, I. N., Petrova, T. V., Svinareva, D. A., Momotuk, K. S., Mikhailova, E. A., & Дризе, Н. И. (2009) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2008.00074.x · Cited by 56
Retrovirus-Specificity of Regulatory T Cells Is Neither Present nor Required in Preventing Retrovirus-Induced Bone Marrow Immune Pathology
Antunes, I., Tolaini, M., Kissenpfennig, A., Iwashiro, M., Kuribayashi, K., MALISSEN, B., Hasenkrug, K. J., & Kassiotis, G. (2008) · Immunity · doi:10.1016/j.immuni.2008.09.016 · Cited by 56
Aplastic Anemia: What Have We Learned From Animal Models and From the Clinic
Scheinberg, P., & Chen, J. (2013) · Seminars in Hematology · doi:10.1053/j.seminhematol.2013.03.028 · Cited by 54
Aplastic Anemia: Pathogenesis and Treatment
Bacigalupo, A. P. (2007) · Hematology · doi:10.1182/asheducation-2007.1.23 · Cited by 53
Severe Aplastic Anemia Associated With Eosinophilic Fasciitis
de Masson, A., Bouaziz, J., de Latour, R. P., Benhamou, Y., Moluçon‐Chabrot, C., Bay, J., Laquerrière, A., Picquenot, J., Michonneau, D., Seguin, V. L., et al. (2013) · Medicine · doi:10.1097/md.0b013e3182899e78 · Cited by 51
The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study
Shin, S., Yoon, J., Yahng, S., Lee, S., Cho, B., Eom, K., Kim, Y., Lee, S., Min, C., Kim, H., et al. (2013) · Annals of Hematology · doi:10.1007/s00277-013-1674-8 · Cited by 51
Indoleamine 2,3-dioxygenase and regulatory T cells in acute myeloid leukemia
Mansour, I., Zayed, R. A., Said, F., & Soliman, L. (2016) · Hematology · doi:10.1080/10245332.2015.1106814 · Cited by 51
Rapamycin is highly effective in murine models of immune-mediated bone marrow failure
Feng, X., Lin, Z., Sun, W., Hollinger, M. K., Desierto, M. J., Keyvanfar, K., Malide, D. A., Muranski, P. J., Chen, J., & Young, N. S. (2017) · Haematologica · doi:10.3324/haematol.2017.163675 · Cited by 50
Self-citation
Abnormalities of quantities and functions of natural killer cells in severe aplastic anemia
Liu, C., Li, Z., Sheng, W., Fu, R., Li, L., Zhang, T., Wu, Y., Xing, L., Song, J., Wang, H., et al. (2014) · Immunological Investigations · doi:10.3109/08820139.2014.888448 · Cited by 47
Circulating myeloid dendritic cells are increased in individuals with severe aplastic anemia
Shao, Z., Tu, M., Huaquan, W., LiMin, X., Wang, J., Fu, R., Liu, H., & Wu, Y. (2011) · International Journal of Hematology · doi:10.1007/s12185-010-0761-z · Cited by 46
Therapeutic potential of FOXP3+ regulatory T cells and their interactions with dendritic cells
Tran, D. Q., & Shevach, E. M. (2009) · Human Immunology · doi:10.1016/j.humimm.2009.02.007 · Cited by 47
Efficacy and safety of mesenchymal stromal cell treatment from related donors for patients with refractory aplastic anemia
Xiao, Y., Jiang, Z., Pang, Y., Li, L., Gao, Y., Xiao, H., Li, Y., Zhang, H., & Liu, Q. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2013.03.007 · Cited by 43
CD4 CD25 Foxp3 regulatory T cells and hematologic malignancies
Kelley, T. W. (2010) · Frontiers in Bioscience-Scholar · doi:10.2741/s114 · Cited by 42
CXCR4 expression on pathogenic T cells facilitates their bone marrow infiltration in a mouse model of aplastic anemia
Kuksin, C. A., González‐Pérez, G., & Minter, L. M. (2015) · Blood · doi:10.1182/blood-2014-08-594796 · Cited by 42
Regulatory T cells: a review.
Dasgupta, A., & Saxena, R. (2012) · PubMed · Cited by 41
Aberrant T cell responses in the bone marrow microenvironment of patients with poor graft function after allogeneic hematopoietic stem cell transplantation
Kong, Y., Wang, Y.-T., Cao, X.-N., Song, Y., Chen, Y., Sun, Y., Wang, Y., Zhang, X., Xu, L., & Huang, X. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1159-y · Cited by 41
Erratum: Human gingiva tissue-derived MSC ameliorates immune-mediated bone marrow failure of aplastic anemia via suppression of Th1 and Th17 cells and enhancement of CD4+Foxp3+ regulatory T cells differentiation.
Zhao, J., Chen, J., Huang, F., Wang, J., Su, W., Zhou, J., Qi, Q., Cao, F., Sun, B., Liu, Z., et al. (2019) · Europe PMC (PubMed Central) · Cited by 39
Aldehyde dehydrogenase 2 in aplastic anemia, Fanconi anemia and hematopoietic stem cells
Wassenhove, L. D. V., Mochly‐Rosen, D., & Weinberg, K. I. (2016) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2016.07.004 · Cited by 40
Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia
Hayakawa, J., Kanda, J., Akahoshi, Y., Harada, N., Kameda, K., Ugai, T., Wada, H., Ishihara, Y., Kawamura, K., Sakamoto, K., et al. (2017) · International Journal of Hematology · doi:10.1007/s12185-017-2179-3 · Cited by 36
Hematologic recovery induced by eltrombopag in Japanese patients with aplastic anemia refractory or intolerant to immunosuppressive therapy
Yamazaki, H., Ohta, K., Iida, H., Imada, K., Obara, N., Tokumine, Y., Tomiyama, Y., Usuki, K., Imajo, K., Miyamura, K., et al. (2019) · International Journal of Hematology · doi:10.1007/s12185-019-02683-1 · Cited by 36
Hypoplastic myelodysplastic syndrome and acquired aplastic anemia: Immune‑mediated bone marrow failure syndromes (Review)
Votavová, H., & Beličková, M. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5297 · Cited by 37
Activity of eltrombopag in severe aplastic anemia
Scheinberg, P. (2018) · Hematology · doi:10.1182/asheducation-2018.1.450 · Cited by 36
Abnormal quantity and function of regulatory T cells in peripheral blood of patients with severe aplastic anemia
Li, Y., Fu, R., Liu, H., Wang, H., Liu, C., Wang, T., Qi, W., Guan, J. Z., Li, L., & Shao, Z. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2015.04.001 · Cited by 36
Optimization of Therapy for Severe Aplastic Anemia Based on Clinical, Biologic, and Treatment Response Parameters: Conclusions of an International Working Group on Severe Aplastic Anemia Convened by the Blood and Marrow Transplant Clinical Trials Network, March 2010
Pulsipher, M. A., Young, N. S., Tolar, J., Risitano, A. M., Deeg, H. J., Anderlini, P. N., Calado, R. T., Kojima, S., Eapen, M., Harris, R., et al. (2010) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2010.10.028 · Cited by 34
Self-citation
Deficit of circulating CD19+CD24hiCD38hi regulatory B cells in severe aplastic anaemia
Zaimoku, Y., Patel, B. A., Kajigaya, S., Feng, X., Alemu, L., Raffo, D. Q., Groarke, E. M., & Young, N. S. (2020) · British Journal of Haematology · doi:10.1111/bjh.16651 · Cited by 35
Self-citation
Th1/17 cells, a subset of Th17 cells, are expanded in patients with active systemic lupus erythematosus
Tsanaktsi, A., Solomou, E. E., & Liossis, S. C. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.08.005 · Cited by 32
Self-citation
Mesenchymal Stem Cells in Immune-Mediated Bone Marrow Failure Syndromes
Kastrinaki, M.-C., Pavlaki, K. I., Batsali, A. K., Kouvidi, E., Mavroudi, I., Pontikoglou, C. G., & Papadaki, H. Α. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/265608 · Cited by 33
Treg sensitivity to FasL and relative IL-2 deprivation drive idiopathic aplastic anemia immune dysfunction
Lim, S. P., Costantini, B., Mian, S. A., Abellan, P. P., Gandhi, S., Martínez‐Llordella, M., Lozano, J. J., Reis, R. A. D., Povoleri, G. A. M., Mourikis, T. P., et al. (2020) · Blood · doi:10.1182/blood.2019001347 · Cited by 31
Effect of Aerobic Exercise on Treg and Th17 of Rats with Ischemic Cardiomyopathy
Chen, Z., Yan, W., Mao, Y., Ni, Y., Zhou, L., Song, H., Xu, W., Wang, L., & Shen, Y. (2018) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-018-9794-0 · Cited by 29
Salidroside affects the Th17/Treg cell balance in aplastic anemia via the STAT3/HIF-1α/RORγt pathway
Liu, Z., Chen, L., Xiong, D., Zhan, Y., Liu, J., Ouyang, L., Chen, W., Lu, Z., Gao, T., Li, X., et al. (2023) · Redox Report · doi:10.1080/13510002.2023.2225868 · Cited by 31
Acquired Aplastic Anemia in Childhood
Guinan, E. C. (2009) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2009.01.011 · Cited by 28
Impaired immunomodulatory ability of bone marrow mesenchymal stem cells on CD4+ T cells in aplastic anemia
Li, J., Lu, S., Yang, S., Xing, W., Feng, J., Li, W., Zhao, Q., Wu, H., Ge, M., Ma, F., et al. (2012) · Results in Immunology · doi:10.1016/j.rinim.2012.07.002 · Cited by 28
Immune-mediated bone marrow failure in C57BL/6 mice
Chen, J., Desierto, M. J., Feng, X., Biancotto, A., & Young, N. S. (2014) · Experimental Hematology · doi:10.1016/j.exphem.2014.12.006 · Cited by 27
Self-citation
The optimal immunosuppressive therapy for aplastic anemia
Shin, S., & Lee, J. W. (2013) · International Journal of Hematology · doi:10.1007/s12185-013-1331-y · Cited by 27
Intravenous infusion of allogeneic mesenchymal stromal cells in refractory or relapsed aplastic anemia
Clé, D. V., Santana-Lemos, B. A. A., Tellechea, M. F., Prata, K. L., Orellana, M. D., Covas, D. T., & Calado, R. T. (2015) · Cytotherapy · doi:10.1016/j.jcyt.2015.09.006 · Cited by 27
Interleukin‐27 enhances the production of tumour necrosis factor‐α and interferon‐γ by bone marrow T lymphocytes in aplastic anaemia
Li, J., Zhao, Q., Xing, W., Feng, J., Wu, H., Li, H., Ge, M., Tian, K. L., Li, X., Zhou, J., et al. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08431.x · Cited by 26
Plasma Metabolomic and Intestinal Microbial Analyses of Patients With Severe Aplastic Anemia
Shao, Y., Qi, W., Zhang, X., Ran, N., Liu, C., Fu, R., & Shao, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.669887 · Cited by 27
CD4+CD25highFoxP3+ Regulatory T-cells in Hematologic Diseases
Moon, H., Kim, B. H., Park, C. M., Hur, M., Yun, Y., Kim, S., & Lee, M. H. (2011) · Annals of Laboratory Medicine · doi:10.3343/kjlm.2011.31.4.231 · Cited by 25
Diversity, localization, and (patho)physiology of mature lymphocyte populations in the bone marrow
Schürch, C. M., Caraccio, C., & Nolte, M. A. (2021) · Blood · doi:10.1182/blood.2020007592 · Cited by 26
APLASTIC ANEMIA AND VIRAL HEPATITIS
Cudillo, L. (2009) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2009.026 · Cited by 24
ATG plus Cyclosporine Reduces All-Cause Mortality in Patients with Severe Aplastic Anemia – Systematic Review and Meta-Analysis
Gafter‐Gvili, A., Ram, R., Gurion, R., Paul, M., Yeshurun, M., Raanani, P., & Shpilberg, O. (2008) · Acta Haematologica · doi:10.1159/000203403 · Cited by 24
Levamisole Suppresses CD4+ T-Cell Proliferation and Antigen-Presenting Cell Activation in Aplastic Anemia by Regulating the JAK/STAT and TLR Signaling Pathways
Wang, J., Liu, J., Wang, M., Zhao, F., Ge, M., Liu, L., Jiang, E., Feng, S., Han, M., Pei, X., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.907808 · Cited by 23
The herbal decoction modified Danggui Buxue Tang attenuates immune-mediated bone marrow failure by regulating the differentiation of T lymphocytes in an immune-induced aplastic anemia mouse model
Deng, P., Li, X., Wei, Y., Liu, J., Chen, M., Xu, Y., Dong, B., Zhu, L., & Chai, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180417 · Cited by 23
Postvaccination graft dysfunction/aplastic anemia relapse with massive clonal expansion of autologous CD8+ lymphocytes
Ritz, C., Meng, W., Stanley, N. L., Baroja, M. L., Xu, C. B., Yan, P., Huang, A. C. C., Hausler, R. M., Nicholas, P., Fan, J., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000853 · Cited by 23
Combined therapy of CD4+CD25+ regulatory T cells with low-dose sirolimus, but not calcineurin inhibitors, preserves suppressive function of regulatory T cells and prolongs allograft survival in mice
Ma, A., Qi, S., Wang, Z., Massicotte, E., Dupuis, M., Daloze, P., & Chen, H. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.01.033 · Cited by 23
Deficiency of regulatory T cells in children with autoimmune neutropenia
Nakamura, K., Miki, M., Mizoguchi, Y., Karakawa, S., Sato, T., & Kobayashi, M. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07662.x · Cited by 23
Immunosuppressive therapy in severe aplastic anemia
Patel, B. A., Townsley, D. M., & Scheinberg, P. (2022) · Seminars in Hematology · doi:10.1053/j.seminhematol.2022.01.002 · Cited by 22
Aplastic Anemia as a Roadmap for Bone Marrow Failure: An Overview and a Clinical Workflow
Solimando, A. G., Palumbo, C., Pragnell, M. V., Bittrich, M., Argentiero, A., & Krebs, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911765 · Cited by 26
Cyclosporine restores hematopoietic function by compensating for decreased Tregs in patients with pure red cell aplasia and acquired aplastic anemia
Dao, A. T. T., Yamazaki, H., Takamatsu, H., Sugimori, C., Katagiri, T., Maruyama, H., Zaimoku, Y., Maruyama, K., Ly, Q. T., Espinoza, L., et al. (2016) · Annals of Hematology · doi:10.1007/s00277-016-2629-7 · Cited by 22
Panaxdiol Saponins Component Promotes Hematopoiesis and Modulates T Lymphocyte Dysregulation in Aplastic Anemia Model Mice
Zheng, Z., Yu, X., Dai, T.-Y., Yin, L., Zhao, Y., Xu, M., Zhuang, H., Chong, B. H., & Gao, R.-L. (2019) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-019-3049-z · Cited by 22
Recent Advances and Long-Term Results of Medical Treatment of Acquired Aplastic Anemia
Scheinberg, P. (2018) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2018.03.003 · Cited by 22
Somatic Mutations in Aplastic Anemia
Mufti, G. J., & Marsh, J. C. W. (2018) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2018.03.002 · Cited by 21
Coeliac disease and aplastic anaemia: a specific entity?
Salmeron, G., Patey, N., de Latour, R. P., Raffoux, E., Gluckman, É., Brousse, N., Socié, G., & Robin, M. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07719.x · Cited by 20
A Marked Decrease in CD4-positive Lymphocytes at the Onset of Hepatitis in a Patient With Hepatitis-associated Aplastic Anemia
Ikeda, T., Morimoto, A., Nakamura, S., Yokoyama, K., Hayase, T., Oh, Y., Kashii, Y., Yotsumoto, S., Okamoto, H., & Momoi, M. Y. (2012) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e31822bf699 · Cited by 20
IL-11 promotes the treatment efficacy of hematopoietic stem cell transplant therapy in aplastic anemia model mice through a NF-κB/microRNA-204/thrombopoietin regulatory axis
Wang, Y., Niu, Z.-Y., Guo, Y., Wang, L., Lin, F.-R., & Zhang, J. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.217 · Cited by 19
Repair of dysfunctional bone marrow endothelial cells alleviates aplastic anemia
Tang, S.-Q., Xing, T., Lyu, Z., Guo, L., Mi, L., Li, C., Zhang, Y., Wang, Y., Xu, L., Zhang, X., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-022-2310-x · Cited by 18
Immune markers of disease severity and treatment response in pediatric acquired aplastic anemia
Sutton, K. S., Shereck, E. B., Nemecek, E. R., & Kurre, P. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24247 · Cited by 18
High programmed death 1 expression on T cells in aplastic anemia
Zhao, W., Zhang, Y., Zhang, P., Yang, J., Zhang, L., He, A., Zhang, W., & Tamura, H. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.01.016 · Cited by 18
Saponins from Panax notoginseng leaves improve the symptoms of aplastic anemia and aberrant immunity in mice
Zhao, Y., Sun, X., Yu, X., Gao, R.-L., & Yin, L. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.175 · Cited by 18
Severe Aplastic Anemia After Receiving SARS-CoV-2 Moderna mRNA Vaccination
Sridhara, S., Nair, R., & Stanek, M. (2022) · Journal of Hematology · doi:10.14740/jh954 · Cited by 18
Immunosuppressive therapies in the management of acquired immune-mediated marrow failures
Risitano, A. M. (2011) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32834da9a4 · Cited by 17
Hematopoietic stem cell mobilization with plerixafor in sickle cell disease
Hsieh, M. M., & Tisdale, J. F. (2018) · Haematologica · doi:10.3324/haematol.2018.190876 · Cited by 16
Yin and Yang of mesenchymal stem cells and aplastic anemia
Broglie, L. A., Margolis, D. M., & Medin, J. A. (2017) · World Journal of Stem Cells · doi:10.4252/wjsc.v9.i12.219 · Cited by 17
Single-cell genomics in acquired bone marrow failure syndromes
Wu, Z., & Young, N. S. (2023) · Blood · doi:10.1182/blood.2022018581 · Cited by 19
Self-citation
CTLA‐4 and HLA‐DQ are key molecules in the regulation of mDC‐mediated cellular immunity by Tregs in severe aplastic anemia
Liu, B., Shao, Y., Liang, X., Lu, D., Li, Y., Churov, A. V., & Fu, R. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23443 · Cited by 16

Authors: Solomou, E. E., Rezvani, K., Mielke, S., Malide, D., Keyvanfar, K., Visconte, V., Kajigaya, S., Barrett, A. J., & Young, N. S.
Affiliations: Hematology Branch and
National Institutes of Health (US)
ORCID: Solomou, Elena E.
Rezvani, Katayoun
Mielke, Stephan
Visconte, Valeria
Kajigaya, Sachiko
Young, Neal S.
Venue: Blood
Publisher: American Society of Hematology
Published: 2007-09-01
Volume: 110
Issue: 5
Pages: 1603-1606
ISSN: 0006-4971 (ISSN-L)
1528-0020
DOI: 10.1182/blood-2007-01-066258
PMC: PMC1975843
OpenAlex: W2066935327
Cited by: 225
References: 24
Citations by year: 2026: 11 · 2025: 8 · 2024: 10 · 2023: 11 · 2022: 7 · 2021: 11 · 2020: 21 · 2019: 10 · 2018: 18 · 2017: 19 · 2016: 9 · 2015: 11 · 2014: 11 · 2013: 10 · 2012: 11
FWCI: 4.59
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Blood (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
Topics: Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Health Sciences › Medicine › Hematology › Blood disorders and treatments
Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
Keywords: regulatory T cells, CD4+CD25+ T cells, Foxp3, NFAT1, acquired aplastic anemia, Treg deficiency, immune homeostasis, transcription factors, Treg reprogramming
MeSH terms: Adolescent, Adult, Anemia, Aplastic, Autoimmune Diseases, Cells, Cultured, Female, Gene Expression Regulation, Humans, Male, Middle Aged, Transfection, Autoimmunity, T-Lymphocytes, Regulatory, NFATC Transcription Factors, Forkhead Transcription Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks